retatrutide dosing retatrutide dose clinical trial Dosage for Weight Loss (Chart Included) Unapproved weight loss drug retatrutide

Phase 2 trial data showed a mean body weight reduction of approximately 24% at the 12 mg weekly maintenance dose over 48 weeks

The meal containing eggs was associated with lower post-meal blood glucose levels, reduced feelings of hunger, and decreased food intake over the next 24 hours

Its unique multi-target activity makes it particularly valuable for studying complex cellular signaling pathways

Licensed healthcare providers, such as physicians, nurse practitioners, and physician assistants, can prescribe compounded GLP-1 medications

This clinical trial took place over 48 weeks

The optimal approach for many patients involves combining strategies